Total Inhibin Is a Potential Serum Marker for Epithelial Ovarian Cancer | Zendy

Anastasia Tsigkou | Zendy; Daniele Marrelli | Zendy; Fernando M. Reis | Zendy; Stefano Luisi | Zendy; Agnaldo Lopes da Silva Filho | Zendy; Franco Roviello | Zendy; Sérgio A. Triginelli | Zendy; Felice Petraglia | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Total Inhibin Is a Potential Serum Marker for Epithelial Ovarian Cancer

Author(s) -

Anastasia Tsigkou,

Daniele Marrelli,

Fernando M. Reis,

Stefano Luisi,

Agnaldo Lopes da Silva Filho,

Franco Roviello,

Sérgio A. Triginelli,

Felice Petraglia

Publication year - 2007

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2007-0235

Subject(s) - serous fluid , ovarian cancer , medicine , ovary , tumor marker , breast cancer , menopause , epithelial ovarian cancer , endocrinology , stage (stratigraphy) , cancer , pathology , gastroenterology , biology , paleontology

Total inhibin is the sum of precursors, subunits, and mature molecules of inhibin, which the normal ovary nearly stops to produce after menopause, whereas ovarian tumors still release.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research